Susquehanna International Group’s NxStage Medical Inc. NXTM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q1 | – | Sell |
-15,000
| Closed | -$429K | – | 10478 |
|
|
2018
Q4 | $429K | Sell |
15,000
-3,500
| -19% | -$99.4K | ﹤0.01% | 6325 |
|
|
2018
Q3 | $516K | Hold |
18,500
| – | – | ﹤0.01% | 6460 |
|
|
2018
Q2 | $516K | Buy |
18,500
+3,500
| +23% | +$93.9K | ﹤0.01% | 6717 |
|
|
2018
Q1 | $373K | Sell |
15,000
-9,300
| -38% | -$226K | ﹤0.01% | 7231 |
|
|
2017
Q4 | $589K | Sell |
24,300
-148,200
| -86% | -$3.9M | ﹤0.01% | 6332 |
|
|
2017
Q3 | $4.76M | Buy |
+172,500
| New | +$4.6M | ﹤0.01% | 2555 |
|
|
2016
Q4 | – | Sell |
-47,500
| Closed | -$1.19M | – | 10457 |
|
|
2016
Q3 | $1.19M | Buy |
47,500
+22,300
| +88% | +$520K | ﹤0.01% | 4477 |
|
|
2016
Q2 | $546K | Buy |
25,200
+6,900
| +38% | +$123K | ﹤0.01% | 5977 |
|
|
2016
Q1 | $274K | Buy |
+18,300
| New | +$307K | ﹤0.01% | 7417 |
|
|
2015
Q4 | – | Sell |
-17,800
| Closed | -$281K | – | 10286 |
|
|
2015
Q3 | $281K | Sell |
17,800
-23,200
| -57% | -$372K | ﹤0.01% | 8155 |
|
|
2015
Q2 | $586K | Buy |
41,000
+31,000
| +310% | +$525K | ﹤0.01% | 7296 |
|
|
2015
Q1 | $173K | Buy |
+10,000
| New | +$177K | ﹤0.01% | 8736 |
|
|
2014
Q3 | – | Sell |
-88,000
| Closed | -$1.26M | – | 10236 |
|
|
2014
Q2 | $1.26M | Buy |
+88,000
| New | +$1.15M | ﹤0.01% | 5555 |
|
Other funds holding NXTM
Susquehanna International Group's NXTM Position: Q1 2019 in Review
Susquehanna International Group sold out of NxStage Medical Inc. (NXTM) in Q1 2019, closing a stake of 22,417 shares — an estimated $642K sold.
Susquehanna International Group first reported a position in NXTM in Q4 2013 and held it in 16 quarters. The position peaked at $4.9M in Q2 2017. 1 fund tracked by Wall St. Rank holds NXTM as of Q1 2019.
- Susquehanna International Group reported no remaining NxStage Medical Inc. position as of Q1 2019 after selling out during the quarter.
- Susquehanna International Group sold 22,417 NxStage Medical Inc. shares in Q1 2019, an estimated $642K.
- Susquehanna International Group first reported a position in NxStage Medical Inc. in Q4 2013 and held it in 16 quarters.
- Susquehanna International Group's NxStage Medical Inc. position peaked at $4.9M in Q2 2017.
- 1 fund tracked by Wall St. Rank held NxStage Medical Inc. as of Q1 2019.
Based on Susquehanna International Group's 13F filing for Q1 2019, filed 15 May 2019.